lysergic acid diethylamide has been researched along with Neuroleptic Malignant Syndrome in 2 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A detailed pathological description of the muscle findings in a case of the neuroleptic malignant syndrome (NMS) following ingestion of lysergic acid diethylamide (LSD) is given, including the first ultrastructural analysis." | 7.68 | The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide. ( Bakheit, AM; Behan, PO; Behan, WM; More, IA, 1991) |
| "A detailed pathological description of the muscle findings in a case of the neuroleptic malignant syndrome (NMS) following ingestion of lysergic acid diethylamide (LSD) is given, including the first ultrastructural analysis." | 3.68 | The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide. ( Bakheit, AM; Behan, PO; Behan, WM; More, IA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behan, WM | 1 |
| Bakheit, AM | 2 |
| Behan, PO | 2 |
| More, IA | 1 |
| Prach, AT | 1 |
| Rittey, CD | 1 |
| Scott, AJ | 1 |
2 other studies available for lysergic acid diethylamide and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.
Topics: Adult; Biopsy; Humans; Lysergic Acid Diethylamide; Male; Microscopy, Electron; Muscles; Myofibrils; | 1991 |
A syndrome identical to the neuroleptic malignant syndrome induced by LSD and alcohol.
Topics: Adult; Diagnosis, Differential; Ethanol; Humans; Lysergic Acid Diethylamide; Male; Neuroleptic Malig | 1990 |